Correlation Between Onconova Therapeutics and Protokinetix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Onconova Therapeutics and Protokinetix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onconova Therapeutics and Protokinetix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onconova Therapeutics and Protokinetix, you can compare the effects of market volatilities on Onconova Therapeutics and Protokinetix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onconova Therapeutics with a short position of Protokinetix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onconova Therapeutics and Protokinetix.

Diversification Opportunities for Onconova Therapeutics and Protokinetix

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Onconova and Protokinetix is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and Protokinetix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protokinetix and Onconova Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onconova Therapeutics are associated (or correlated) with Protokinetix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protokinetix has no effect on the direction of Onconova Therapeutics i.e., Onconova Therapeutics and Protokinetix go up and down completely randomly.

Pair Corralation between Onconova Therapeutics and Protokinetix

If you would invest  1.07  in Protokinetix on September 30, 2024 and sell it today you would lose (0.07) from holding Protokinetix or give up 6.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy1.54%
ValuesDaily Returns

Onconova Therapeutics  vs.  Protokinetix

 Performance 
       Timeline  
Onconova Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onconova Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Onconova Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Protokinetix 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.

Onconova Therapeutics and Protokinetix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Onconova Therapeutics and Protokinetix

The main advantage of trading using opposite Onconova Therapeutics and Protokinetix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onconova Therapeutics position performs unexpectedly, Protokinetix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protokinetix will offset losses from the drop in Protokinetix's long position.
The idea behind Onconova Therapeutics and Protokinetix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance